More News! 16 Sep 2022Strategic collaboration for drug to treat NASH, obesity and diabetes announced A conditional and exclusive license agreement to develop and commercialize a drug to treat nonalcoholic steatohepatitis (NASH), obesity and type… September 16, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email